Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-12-03
1981-08-04
Hines, Robert V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2605011, 26050118, 26050119, 26050121, 424330, 564273, 564274, 564275, 564363, 564364, 564365, 564366, 564383, 564386, 564387, 564342, 564343, 568425, 568426, A01N 3302, A01N 3730, C07C 8728
Patent
active
042822513
ABSTRACT:
Cinnamylalkyl-1-naphthylmethylamines, useful as antimycotic agents, and processes for their production.
REFERENCES:
patent: 2601275 (1952-06-01), Gump et al.
patent: 2609392 (1952-09-01), Crossley
patent: 3094561 (1963-06-01), Faust et al.
patent: 3366688 (1968-01-01), Hargrove
patent: 3829469 (1974-08-01), Thiele et al.
Biniecki et al. (I), "Chemical Abstracts", vol. 50, pp. 4096-4097 (1956).
Biniecki et al. (II), "Chemical Abstracts", vol. 49, p. 8153 (1955).
Gunn et al., "Chemical Abstracts", vol. 34, p. 8064.
Wagner et al., "Synthetic Organic Chemistry", pp. 666-669 (1953).
Hines Robert V.
Honor Robert S.
McGovern Thomas O.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Trans-n-cinnamyl-n-methyl-(1-naphthylmethyl)amine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trans-n-cinnamyl-n-methyl-(1-naphthylmethyl)amine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-n-cinnamyl-n-methyl-(1-naphthylmethyl)amine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240443